Digestion and absorption of lipids is a highly efficient process. From
Western diets about 95% will be absorbed. This implies that together
with lipids from endogenous sources 6-8 g of lipids will enter the col
on daily. This input significantly increases during various lipid mala
bsorption syndromes. It has long been assumed that the biological fate
of unabsorbed lipids is physiologically not relevant. However, signif
icant microbial lipid metabolism occurs. Circumstantial evidence is ar
ising which supports a role of unabsorbed lipid metabolites in the dev
elopment of colonic diseases. Lipid metabolites may act as detergents
in the colon, leading to mucosal injury and reactive hyperproliferatio
n, which in its turn could promote tumour development. Lipid metabolit
es could also be transformed in biological active metabolites, which h
ave a tumour promoting potency. More mechanistic information is needed
on the colonic metabolic fate of lipids in order to develop strategie
s for manipulating colonic flora in the prevention of lipid related co
lonic diseases.